Picture of Alkermes logo

ALKSV — Alkermes News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapNeutral

Alkermes Plc expected to post a loss of 2 cents a share - Earnings Preview

* Alkermes Plc  ALKS.OQ   ALKS.O  is expected to show a rise
in
quarterly revenue when it reports  results on April 26. 
    * The Dublin-based  company is expected to report  a
1.3% increase
in revenue to $282.179 million from $278.55 million a year ago,
according to the mean estimate from 9 analysts, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Alkermes Plc is for
a
loss of 2 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 12.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Alkermes
Plc is
$32​, above​ its last closing price of $29.38. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.05        0.05       0.14      Beat    207.3
 Sep. 30 2022  0.06        0.03       0.02      Missed  -34.1
 Jun. 30 2022  0.03        0.01       0.06      Beat    740.3​
 Mar. 31 2022  0.01        0.01       0.12      Beat    1,066.
                                                        2
 ​​Dec.        0.08        0.08       0.23      Beat    182.5
 31 2021                                                
 Sep. 30 2021  0.09        0.06       0.14      Beat    125.8​
 Jun. 30 2021  0.15        0.12       0.30      Beat    147.1
 Mar. 31 2021  -0.02       -0.02      0.11      Beat    718.8
 This summary was machine generated April 24 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Alkermes

See all news